Primary care physicians should be on the lookout for recurrent arrhythmias after a new study finds that among 1 in 3 patients, AF recurs after discharge from the hospital.
Heather Moore, CPP, PharmD, highlights key contributions from pharmacists in breast cancer treatment and identifies current unmet needs in the treatment landscape.
With implications for sudden-death risk assessment, 30-day compared to 24-hour monitoring may detect far more clinically important arrhythmias in patients with hypertrophic cardiomyopathy.